FDA Announces New Initiative for Real-Time Clinical Trials
Date: June 23, 2026
The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the implementation of real-time clinical trials, with pilot studies exploring how regulators can review clinical trial data as it becomes available.
For clinical data management professionals, the announcement highlights the increasing importance of high-quality, timely and well-governed data to support evolving approaches to clinical research.
Read the full FDA announcement to learn more about the initiative and its potential impact on the future of clinical trials: https://www.fda.gov/news-events/press-announcements/fda-announces-major-steps-implement-real-time-clinical-trials
Explore More News

ICH E6(R3) Guideline reaches Step 4 of the ICH Process
ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025.
The guideline . . .
Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties
The U.S. Food and Drug Administration has issued its first guidance on the use of . . .
Read More

ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025
As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .
Read More

Audit Trail Review DMEG Update – New Guide
The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .
Read More

Risk Based Quality Management DMEG Update – Recent Discussions
This year our focus has switched away from generalised RBQM to applying risk-based . . .
Read More

Regulatory Considerations DMEG Update – September 2024
The Regulatory Considerations DMEG are waiting for the release of ICH GCP E6 (R3) Annex 1 . . .
Read More

Digital Data Flow (DDF) integration through the lens of electronic Patient-Reported Outcomes (ePRO)
This article has been submitted by Leeni Joshua of ICON plc
Introduction:
Digital Data . . .
Read More

Guidance for Industry: Conducting Clinical Trials With Decentralized Elements
The Conducting Clinical Trials With Decentralized Elements final guidance has now been . . .
Read More

Welcome FGK Clinical Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome FGK Clinical . . .
Read More

Welcome LINK Medical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome LINK Medical as . . .
Read More

Welcome Zilla Clinicals as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Zilla Clinicals . . .
Read More

Challenge ChatGPT: CDMs vs AI
Following a recent Hot Topic discussion that explained how machine learning models are . . .
Read More